R1	Has_qualifier Arg1:T2 Arg2:T1	
R2	Has_temporal Arg1:T5 Arg2:T6	
R3	Has_multiplier Arg1:T5 Arg2:T4	
R4	Has_qualifier Arg1:T8 Arg2:T9	
R5	Has_index Arg1:T12 Arg2:T13	
R6	multi Arg1:T13 Arg2:T14	
R7	Has_multiplier Arg1:T11 Arg2:T10	
R8	Has_multiplier Arg1:T8 Arg2:T7	
*	OR T8 T11
R9	Has_qualifier Arg1:T15 Arg2:T16	
R10	Has_temporal Arg1:T5 Arg2:T12	
R11	AND Arg1:T14 Arg2:T15	
R12	Has_temporal Arg1:T19 Arg2:T20	
R13	Has_multiplier Arg1:T19 Arg2:T18	
R14	Has_value Arg1:T21 Arg2:T22	
R15	Has_temporal Arg1:T8 Arg2:T12	
T1	Qualifier 0 13	Highly active
T2	Condition 14 17	RMS
T3	Non-representable 18 32	as defined by:
T4	Multiplier 34 37	One
T5	Condition 38 45	relapse
T6	Temporal 46 66	in the previous year
T7	Multiplier 71 81	at least 1
T8	Condition 102 108	lesion
T9	Qualifier 82 101	T1 Gadolinium (Gd)+
T10	Multiplier 112 121	9 or more
T11	Condition 122 132	T2 lesions
T12	Temporal 134 150	while on therapy
T13	Reference_point 143 150	therapy
T14	Procedure 143 150	therapy
T15	Drug 162 192	disease modifying drugs (DMDs)
T16	Qualifier 156 161	other
T18	Multiplier 194 205	Two or more
T19	Condition 206 214	relapses
T20	Temporal 215 235	in the previous year
T21	Measurement 271 316	Expanded Disability Status Scale (EDSS) score
T22	Value 317 345	less than equals to (<=) 5.0
T23	Post-eligibility 348 402	Other protocol defined inclusion criteria could apply.
